New York, NY · Founded 2019 · Privately Held (backing)
Operator of a human-enabled machine-driven drug design company intended for biomedical research and drug discovery. Ordaos is based in New York, NY and was founded in 2019. Its last reported valuation was $110 million in Nov 2024. It has raised $24.5 million across 6 recorded rounds; the latest was a $337,705 seed round in Feb 2025.
Last reported valuation
$110.0M
Oct 2026
Priced at
—
Total raised
$24.5M
Last round
Seed Round
Feb 2025
Cap table — not yet on record
Ordaos's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Ordaos with a free account
·The complete investor list: 16 names
·Watch Ordaos: the Monday email on marks, rounds and moves